Fortress Biotech, Inc. (FBIO) Financials

FBIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 316.7 million 110.6 million
March 31, 2026 356.9 million 154.5 million
Dec. 31, 2025 185.5 million 123.4 million
Sept. 30, 2025 181.4 million 116.2 million

FBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -59.4 million ?
March 31, 2026 203.9 million 1.8 million
Dec. 31, 2025 -12.5 million 2.5 million
Sept. 30, 2025 -6.1 million 3.2 million

FBIO Net Income

No data available :(

FBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 196.6 million 46.1 million 11.5 million
March 31, 2026 255.8 million 36.9 million 14.2 million
Dec. 31, 2025 79.4 million 59.5 million 14.8 million
Sept. 30, 2025 86.2 million 47.8 million 14.9 million

FBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 31.8 million
March 31, 2026 38.4 million
Dec. 31, 2025 279.0 million
Sept. 30, 2025 33.1 million

FBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 79000 805000 20.8 million -
March 31, 2026 - 540000 15.9 million -
Dec. 31, 2025 - -367000 14.7 million -
Sept. 30, 2025 - 208000 17.4 million -

FBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 18.7 million 7.1 million
March 31, 2026 16.0 million 7.3 million
Dec. 31, 2025 16.1 million 5.4 million
Sept. 30, 2025 17.6 million 5.8 million

FBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

FBIO

Price: $1.87

52 week price:
1.87
4.53

Payout Ratio Range:
-62.12%
42.10%

Earnings Per Share: 2.68 USD

P/E Ratio: 1.05

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 340489

Ebitda: -32.4 million

Market Capitalization: 67.4 million

Links: